Monday January 27, 2020

Irish biomaterials company sold to Ashland for $12m

23rd December, 2018
Sean McMahon

An Irish company that develops biomaterial solutions for the pharma and medical devices sector has been sold for $12 million to global chemical company Ashland.

Vornia produces a range of medical biomaterials for the pharmaceutical, cosmetic and medical devices industry, as well as for academic and industrial clients. Biomaterials are biological or synthetic substances which can be introduced into body tissue. Vornia’s biomaterial platform technologies can be applied in 3D bioprinting, drug and gene delivery and...

Subscribe from just €1 for the first month!

Exclusive offers:

All Digital Access + eReader

Trial

€1

Unlimited Access for 1 Month

Then €19.99 a month after the offer period.

Get basic
*New subscribers only
You can cancel any time.

Annual

€200

€149 For the 1st Year

Unlimited Access for 1 Year

You can cancel any time.

Quarterly

€55

€42

90 Day Pass

You can cancel any time.

Team Pass

Get a Business Account for you and your team

Related Stories

The HSE has a funding crisis. Unless it is solved, the Sláintecare health reform programme cannot be implemented

Tony O'Brien | 1 day ago

After two crashes and 346 deaths, the aircraft manufacturer’s new 737 Max has been grounded. It has since emerged that the plane was rushed through production, with pilots kept in the dark about a new control system, and no one seems be sure when it will be ready for takeoff again

Barry J Whyte | 1 day ago

Allowing our super-rich to go under the radar ensures that the wealth gap in Ireland is just as entrenched as in other parts of the world

Vincent Boland | 1 day ago